Elumbaring, Carmelita V.

HRN: 28-21-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/09/2025
12/16/2025
IV
2.25
Q12H
Tc CAP HR. Internal Progression Of Right Side Infiltrates
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: